pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Congressional Bill Aims to End Arbitration in No Surprises Act, Shifting Payments to Median In-Network Rates

Oct 8, 2026·read at STAT ↗RegulatoryNeutral

Rep. Frank Pallone introduced the Lower Premiums, Faster Payments Act, which would eliminate the arbitration system used under the No Surprises Act and replace it with a payment model based on median in‑network rates.

The proposal has drawn praise from academics and consumer‑advocacy groups who view the current arbitration process as costly and opaque. Provider organizations, however, have launched strong opposition, arguing that arbitration has been a lucrative mechanism for them.

If the legislation survives congressional debate, it could reshape how out‑of‑network disputes are settled, potentially lowering costs for insurers and patients while reducing revenue streams for some providers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: House Democrat seeks to scrap No Surprises Act’s costly arbitration process”

read at STAT ↗
509 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7

related stories

  • Jul 14STAT+: Hospital chain HCA warns of lower profits as more patients go uninsuredSTAT
  • Jul 13Caregivers brace for pay cuts, and maybe homelessnessSTAT
  • Jul 2STAT+: Medicare takes another swing at 340B cuts to hospitalsSTAT
  • Jun 295 takeaways from STAT’s investigation into microhospital operator Nutex HealthSTAT
  • Jun 18STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims dataSTAT